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Ignicoccus hospitalis is an autotrophic hyperthermophilic archaeon that serves as a host for another parasitic/
symbiotic archaeon, Nanoarchaeum equitans. In this study, the biosynthetic pathways of I. hospitalis were
investigated by in vitro enzymatic analyses, in vivo 13C-labeling experiments, and genomic analyses. Our
results suggest the operation of a so far unknown pathway of autotrophic CO2 fixation that starts from
acetyl-coenzyme A (CoA). The cyclic regeneration of acetyl-CoA, the primary CO2 acceptor molecule, has not
been clarified yet. In essence, acetyl-CoA is converted into pyruvate via reductive carboxylation by pyruvate-
ferredoxin oxidoreductase. Pyruvate-water dikinase converts pyruvate into phosphoenolpyruvate (PEP), which
is carboxylated to oxaloacetate by PEP carboxylase. An incomplete citric acid cycle is operating: citrate is
synthesized from oxaloacetate and acetyl-CoA by a (re)-specific citrate synthase, whereas a 2-oxoglutarate-
oxidizing enzyme is lacking. Further investigations revealed that several special biosynthetic pathways that
have recently been described for various archaea are operating. Isoleucine is synthesized via the uncommon
citramalate pathway and lysine via the -aminoadipate pathway. Gluconeogenesis is achieved via a reverse
Embden-Meyerhof pathway using a novel type of fructose 1,6-bisphosphate aldolase. Pentosephosphates are
formed from hexosephosphates via the suggested ribulose-monophosphate pathway, whereby formaldehyde is
released from C-1 of hexose. The organism may not contain any sugar-metabolizing pathway. This compre-
hensive analysis of the central carbon metabolism of I. hospitalis revealed further evidence for the unexpected
and unexplored diversity of metabolic pathways within the (hyperthermophilic) archaea.
Ignicoccus hospitalis is a recently described member of the
crenarchaeal order Desulfurococcales (38). Like the two other
described Ignicoccus species, Ignicoccus islandicus and Ignicoc-
cus pacificus (24), it is a strictly anaerobic, hyperthermophilic
archaeon with an optimal growth temperature of 90°C. All
Ignicoccus species grow chemolithoautotrophically, using the
reduction of elemental sulfur with molecular hydrogen as the
sole energy source and CO2 as the sole carbon source. They
possess a unique ultrastructure of the cell envelope with an
outer membrane resembling that of gram-negative bacteria
(40). Despite the great similarities, I. hospitalis shows a unique
feature: it is the only known host of Nanoarchaeum equitans, a
representative of the archaeal kingdom Nanoarchaeota. The
two organisms represent the only known purely archaeal host-
parasite system (25). As the smallest archaeal genome of N.
equitans (490 kbp) lacks nearly all genes for biosynthetic path-
ways (48), it is likely that I. hospitalis provides all essential
biosynthetic building blocks, like lipids or amino acids, for N.
equitans (32).
The genome of I. hospitalis has also been sequenced (http:
//genome.jgi-psf.org/draft_microbes/ign_k/ign_k.draft.html). It
is the second smallest archaeal genome known and exhibits
only 1,434 putative genes, clearly indicating a high metabolic
specialization of I. hospitalis. To maintain a continuous supply
of organic carbon, I. hospitalis assimilates CO2 into low-mo-
lecular-weight building blocks for biosynthesis. At present,
four pathways of CO2 fixation are known: the Calvin-Bassham-
Benson cycle, the reductive citric acid cycle, the reductive
acetyl-coenzyme A (CoA) pathway, and the 3-hydroxpropi-
onate cycle, with a modified version present in the crenar-
chaeal order Sulfolobales (34). Preliminary experiments with I.
pacificus and I. islandicus indicated that these autotrophic
members of the Desulfurococcales lack the key enzymes of
all these autotrophic pathways (28), raising the question of
whether the members of the genus Ignicoccus use a new or
modified pathway of autotrophic CO2 fixation.
Another central biosynthetic process is gluconeogenesis. It is
believed that gluconeogenesis in Bacteria and Archaea is
achieved by the reversed Embden-Meyerhof pathway; in con-
trast to a rather uniform gluconeogenetic pathway, Archaea
use an amazing variety of different pathways for glycolysis (44).
The biosynthesis of pentose phosphate in Archaea is still an
open question. Three possibilities for biosynthesis of pentoses
have been described. The oxidative pentose phosphate path-
way is mainly restricted to bacteria, whereas the nonoxidative
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pentose phosphate pathway was found in several methanogens
on the basis of enzymatic and genomic analyses (43, 50). In
archaea lacking the genes for the nonoxidative or the oxidative
pentose phosphate pathway, the ribulose-monophosphate
pathway was recently suggested as an alternative for pentose
phosphate biosynthesis, on the basis of genome analyses. In
this pathway, pentose phosphate is synthesized by the release
of formaldehyde from 3-hexulose 6-phosphate (13, 33, 45).
In this work, we investigated the autotrophic CO2 fixation
pathway of I. hospitalis and the biosynthesis of representative
main cellular building blocks. Enzymatic analyses in vitro were
combined with retrobiosynthetic analyses of in vivo 13C-labeled
amino acids. The experimental data were compared to the
genome data of I. hospitalis to obtain comprehensive insight
into the central metabolism in the organism. We suggest
that I. hospitalis uses a novel, so far unknown pathway of
CO2 fixation.
MATERIALS AND METHODS
Strains and culture conditions. I. hospitalis strain KIN4/IT was obtained from
our culture collection and grown in synthetic-seawater medium, pH 5.5 (26),
under a gas phase of H2-CO2 (80%/20% [vol/vol]) at 90°C. Metallosphaera sedula
strain TH2T (for control experiments) was grown autotrophically as described
previously (27).
Production of 13C-labeled cell masses. I. hospitalis cells were cultivated under
autotrophic growth conditions in a 100-liter enamel-protected fermentor in the
presence of 0.5 mM [1-13C]acetate (Euriso-Top, Gif sur Yvette Cedex, France)
(stirring, 150 rpm; gas phase, 300 kPa without gassing).
Incorporation of organic compounds. The incorporation of organic com-
pounds into I. hospitalis cells was investigated by adding a mixture of unlabeled
and 14C-labeled compounds to the growth medium. [1-14C]acetate (2.0 GBq
mmol1; Amersham Biosciences, Freiburg, Germany), [3-14C]pyruvate (0.6 GBq
mmol1; American Radiolabeled Chemicals, St. Louis, MO), [1,4-14C]succinate
(2.0 GBq mmol1; American Radiolabeled Chemicals, St. Louis, MO), or
[U-14C]glucose (11.7 GBq mmol1; American Radiolabeled Chemicals, St.
Louis, MO), respectively, was added (630, 140, 140, and 165 kBq, respectively,
total radioactivity in a final concentration of 0.5 mM). Cells were grown in 1-liter
serum bottles containing 250 ml medium under a gas pressure of 160 kPa
(H2-CO2; 80/20) at 100 rpm. Samples (50 ml) were retrieved at intervals of 100
to 120 min during the exponential growth phase. The cell concentration was
determined by cell counting using a Neubauer counting chamber. After a cen-
trifugation step (40,000  g; 30 min), the cells were washed with medium lacking
the organic substrate and resuspended in 100 l of fresh synthetic-seawater
medium. Radioactivity was determined within this sample, as well as in 100 and
200 l of the supernatant, by liquid scintillation counting.
Determination of the protein content of I. hospitalis cells. Cells grown in 20 ml
culture medium to about 107 cells ml1 (total, 2  108 cells) were harvested,
washed, and resuspended in 1 ml of double-distilled water. The cells were lysed
by 30-s ultrasonic treatment of the suspension (Sonifier 250; Branson, Danbury,
CT). The protein content of the sample was determined to be 6 g per 107 cells
using the method of Bradford (5).
Syntheses. Malonyl-CoA, succinyl-CoA, acetyl-CoA, propionyl-CoA, L-malyl-
CoA, and 3-hydroxypropionate were synthesized as described elsewhere (21),
and the dry powders of the CoA esters were stored at 20°C.
Preparation of cell extracts. Cell extracts were prepared using a mixer mill
(type MM2; Retsch, Haan, Germany); 0.5 ml buffer (100 mM Tris-HCl, pH 7.8,
3 mM 1,4-dithioerythritol [DTE], and 0.1 mg of DNase I per ml of buffer) and
0.5 g glass beads (diameter, 0.1 to 0.25 mm) were added to 0.1 g of wet cells in
1-ml stoppered glass vials in the anaerobic chamber. The solution was treated in
the mixer mill for 6 min at 100% intensity (30 Hz). Following a centrifugation
step (10 min; 12,000  g; 4°C), the supernatant was used for enzyme tests. For
larger amounts of cell extract, the cell suspension was passed through a French
pressure cell at 137 MPa, and the lysate was ultracentrifuged (1 h; 100,000  g;
4°C). The protein concentration in cell extracts was determined by the method of
Bradford (5), using bovine serum albumin as a standard.
Enzyme assays. Routine enzyme assays (0.5 ml assay mixture) were performed
in stoppered 0.5-ml glass cuvettes or 1-ml glass vials. For practical reasons, unless
otherwise stated, the assay temperature was 75°C or 85°C, as specified in Results
(compared to a 90°C growth temperature).
Assays with NADH, NADPH, NAD, or NADP. Reactions involving
pyridine nucleotides were followed spectrophotometrically at 365 nm
{ε365 nm[NAD(P)H]  3.4  103 M1 cm1}.
ATP citrate lyase, malate dehydrogenase, isocitrate dehydrogenase, aconitase,
pyruvate kinase, 2-oxoglutarate dehydrogenase, and pyruvate dehydrogenase, as
well as the reduction of malonyl-CoA to 3-hydroxypropionate and the reduction
of 3-hydroxypropionate to propionyl-CoA, were measured as described previ-
ously (28). Isocitrate dehydrogenase and aconitase were tested under oxic and
anoxic conditions.
For glyceraldehyde 3-phosphate dehydrogenase, the phosphate- and glyceral-
dehyde 3-phosphate-dependent reduction of NAD(P) was monitored. The as-
say mixture (adjusted to pH 7.8) contained 100 mM Tris-HCl, 100 mM K2HPO4,
2 mM NAD(P), and 3 mM glyceraldehyde 3-phosphate. The addition of
glyceraldehyde 3-phosphate started the reaction. The presence of phosphate-
independent glyceraldehyde 3-phosphate dehydrogenase was tested in an
assay lacking phosphate.
Assays with viologen dyes. Reactions involving methyl viologen (MV) or ben-
zyl viologen (BV) were followed spectrophotometrically at 578 nm [ε578 (MV) 
9.8 103 M1 cm1; ε578 (BV) 8.6 103 M1 cm1] (7). The following anoxic
assay mixture was used with N2 gas as the headspace: 100 mM Tris-HCl, pH 7.8,
4 mM DTE, 2 mM MgCl2, and 4 mM MV or 2 mM BV. Dithionite was added
by syringe from 5 mM stock solution until a permanent faint bluish color was
obtained.
For 2-oxoglutarate– and pyruvate-acceptor oxidoreductases, the assay mixture
contained buffer, 1 mM CoA, and 3 mM 2-oxoglutarate or pyruvate. The reaction
was started by the addition of 2-oxoglutarate or pyruvate. As a control, the assays
were repeated by adding 0.5 mM thiamine-diphosphate to the reaction mixture.
For formate dehydrogenase, the assay mixture contained buffer and 3 mM
formate; the reaction was started by the addition of formate.
For fumarate reductase, before the reaction was started, MV was reduced to
an optical density at 578 nm of about 2.0 with dithionite. The addition of
fumarate started the reaction.
Carbon monoxide dehydrogenase was measured according to a previously
described method (30).
Other spectrophotometric assays. L-Malyl-CoA lyase, isocitrate lyase, fuma-
rate hydratase, and citrate synthase were measured as described by Hu¨gler et al.
(28). All enzyme activities were tested under oxic and anoxic conditions.
Radioactive assays. Carboxylation reactions with 14CO2 were followed by
measuring the substrate-dependent incorporation of 14C from [14C]-bicarbonate
into acid-stable products.
Ribulose 1,5-bisphosphate carboxylase/oxygenase (RubisCO), acetyl-CoA car-
boxylase, propionyl-CoA carboxylase, phosphoenolpyruvate (PEP) carboxylase,
pyruvate carboxylase, PEP carboxykinase, pyruvate water dikinase (PEP syn-
thase), and pyruvate phosphate dikinase were measured according to the method
of Hu¨gler et al. (28).
For 2-oxoglutarate– and pyruvate-acceptor oxidoreductases, the exchange of
14CO2 into the carboxyl group of the 2-oxoacids in the absence of electron
acceptors is characteristic of reversible 2-oxoacid synthases. The following anoxic
assay mixture was used with N2 gas as the headspace: 100 mM Tris-HCl, pH 7.8,
4 mM DTE, 2 mM MgCl2, 10 mM NaHCO3, 37 kBq [14C]Na2CO3 (specific
radioactivity, 2.5 Bq nmol1), and 3 mM 2-oxoglutarate or pyruvate. In some
experiments, 1 mM CoA or 0.5 mM thiamine PPi was included, but without
effect. The reaction was started by the addition of 2-oxoglutarate or pyruvate.
Enzymatic assays coupled to phosphate determination. Reactions resulting in
a substrate-dependent release of inorganic phosphate from the phosphorylated
substrates were followed by measuring the substrate- and cell extract-dependent
increase of inorganic phosphate in the assay (total volume, 0.25 ml). The buffer
contained 100 mM Tris-HCl, pH 7.8, and 5 mM MgCl2. Reaction mixtures were
incubated at 85°C for 0, 2, and 5 min and stopped by rapid cooling on ice.
Experiments in which substrate or cell extract, respectively, were omitted served
as blanks and controls.
For fructose 1,6-bisphosphate phosphatase, the reaction was started by the
addition of 4 mM fructose 1,6-bisphosphate to the reaction mixture.
For fructose 1,6-bisphosphate aldolase, the enzyme activity was determined in
the direction of fructose bisphosphate formation by coupling the reaction to
endogenous fructose 1,6-bisphosphate phosphatase activity, which dephosphory-
lates fructose 1,6-bisphosphate. Glyceraldehyde 3-phosphate (8 mM) was incu-
bated for 10 min at 25°C in the presence of 5 U triosephosphate isomerase.
Afterward, the assay mixture was heated to 85°C and the test was started by the
addition of cell extract. The release of inorganic phosphate from fructose 1,6-
bisphosphate was monitored.
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The glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate kinase
assay detected both activities, although the specific activity observed was that of
the rate-limiting step. The NAD(P)H- and 3-phosphoglycerate-dependent re-
lease of inorganic phosphate from MgATP was followed. The reaction was
coupled to the endogenous phosphoglycerate kinase activity, which forms 1,3-
bisphosphoglycerate from 3-phosphoglycerate and ATP. The reaction mixture
contained 0.5 mM NAD(P)H, 5 mM ATP, and 5 mM 3-phosphoglycerate. The
reaction was started by the addition of 3-phosphoglycerate. The blank reaction in
the absence of ATP was zero, and the blank value obtained in the presence of
ATP and in the absence of NAD(P)H (20 nmol min1 mg1) was subtracted
from the measured values.
Determination of acid-stable 14C. The fixation of 14C from [14C]bicarbonate
into nonvolatile, acid-stable products was measured in samples (0.1 ml) incu-
bated for 1, 5, and 10 min (see above). The addition of 20 l of 6 M HCl (to pH
1 to 2) stopped the reaction. Volatile 14CO2 (nonfixed) was removed by vigor-
ously shaking the sample in open scintillation vials for 3 h. The remaining
radioactivity in the liquid sample was then determined. The radioactivities in
samples of two control experiments, in which the substrate and extract, respec-
tively, were omitted, served as blanks and controls.
Determination of 14C. The amount of 14C in liquid samples (up to 0.2 ml) was
determined by liquid scintillation counting using 3 ml of Rotiszint eco plus
scintillation cocktail (Roth, Karlsruhe, Germany). The counting efficiency (75 to
85%) was determined via the channel ratio method.
Determination of inorganic phosphate. Inorganic phosphate released in en-
zymatic assays was determined using the modified malachite green-ammonium
molybdate assay (22).
Detection of biotinylated proteins. Biotinylated proteins in cell extracts were
detected with peroxidase-conjugated avidin as described previously (12, 35).
Fractionation of cell material. Cells (3 g [wet weight]) were suspended in 3 ml
double-distilled water, and the suspension was treated with a sonifier (Sonifier
250; Branson, Danbury, CT). After cell disruption, 3 ml of 70% (vol/vol) HClO4
was added to precipitate the protein. After 30 min of incubation on ice, a
centrifugation step (15 min; 48,000  g; 4°C) followed. To remove low-molecu-
lar-weight substances, the resulting pellet was washed three times with 10 ml 0.5
M HClO4, followed by centrifugation (5 min; 48,000  g). To extract nucleic
acids, 10 ml 0.5 M HClO4 was added to the pellet, and the solution was incubated
at 70°C for 20 min. After centrifugation (15 min; 20,000  g; 4°C), nucleic acids
stayed in the supernatant and proteins in the pellet. To extract lipids, the pellet
was resuspended in a mixture of ethanol and diethylether (3:1 [vol/vol]) and
incubated at 40°C for 1 h. A centrifugation step (15 min; 20,000  g; 4°C)
separated the protein pellet from lipids in the supernatant. After a wash with 10
ml diethylether and centrifugation (15 min; 20,000  g; 4°C), the protein pellet
was dried by lyophilization (Celvinator Beta 1-16; Christ, Osterode, Germany).
For protein hydrolysis, 3 ml 6 M HCl was added to the protein pellet. The
suspension was incubated in sealed and evacuated glass ampoules at 112°C for
24 h. HCl was removed by three evaporation cycles, with the addition of 20 ml
of double-distilled water after each cycle.
Separation of amino acids. Amino acids were isolated by chromatographic
procedures, as described previously (10).
NMR spectroscopy. 1H and 13C nuclear magnetic resonance (NMR) spectra
were recorded at 500.13 and 125.76 MHz, respectively, with a DRX500 spec-
trometer (Bruker Biospin, Rheinstetten, Germany) as described previously (9).
Tyr and Asp were dissolved in D2O containing 0.1 M NaOD (pH 13); the other
amino acids were dissolved in D2O containing 0.1 M DCl (pH 1). 13C enrich-
ments were determined for individual positions by quantitative NMR spectros-
copy (9). Briefly, 13C NMR spectra of the 13C-labeled compound under study
and of natural-abundance material were recorded under the same experimental
conditions. Integrals were determined for each 13C NMR signal, and the signal
integral for each carbon atom in the labeled compound was referenced to that of
the natural-abundance material, thus affording relative 13C abundances for each
position in the labeled molecular species. Relative abundances were normalized
by assigning a value of 1.1% to the carbon atom with the lowest 13C enrichment.
The validity of this approach was confirmed for certain amino acids by analysis
of 13C coupling satellites in 1H NMR spectra.
Database search. The genome sequence of I. hospitalis was obtained from
http://genome.jgi-psf.org/draft_microbes/ign_k/ign_k.draft.html. Blast searches
for genes encoding metabolic enzymes were performed using the program Clone
Manager (Scientific & Educational Software). Query sequences were obtained
from the Entrez gene database (http://www.ncbi.nlm.nih.gov/entrez/query
.fcgi?CMDsearch&DBgene).
RESULTS
Search for key enzymes of autotrophic pathways. Cell ex-
tracts of I. hospitalis were screened for the presence of enzyme
activities that were considered representative of the four
known autotrophic CO2 fixation pathways. Autotrophic growth
under optimal conditions (90°C; pH 6.0; 1% S0; H2/CO2 ratio,
80%/20% [vol/vol] at 250 kPa) occurred at a generation time of
1 h, corresponding to a specific growth rate () of 0.011 min1.
The cells that were studied grew with a generation time of
approximately 2 h. Assuming a carbon content of 50% of the
dry cell mass, the rate of carbon fixation under these conditions
amounted to 0.4 mol CO2 fixed per min per mg of protein.
This estimate is based on the specific substrate (S) consump-
tion (dS) per time unit (dt): dS/dt  (/Y)X, where Y repre-
sents the growth yield (1 g of dry cell mass formed per 0.5 g of
carbon fixed) and X represents the cell dry mass in g (1 g of cell
dry mass, corresponding to approximately 0.5 g of protein).
The activity of RubisCo, the key enzyme of the Calvin cycle,
was tested as ribulose 1,5-bisphosphate-dependent fixation of
14CO2 into acid-stable products. The specific activity at 80°C
was below 1 nmol min1 mg protein1, indicating that the
Calvin cycle was not operating. Also, neither carbon monoxide
dehydrogenase nor formate dehydrogenase activity—enzyme
activities characteristic of the reductive acetyl-CoA pathway—
was detectable (both were tested with MV as the artificial
electron acceptor), indicating that the reductive acetyl-CoA
pathway was not present, either.
In members of the Sulfolobales, acetyl-CoA/propionyl-CoA
carboxylase is considered a key enzyme of a modified 3-hy-
droxypropionate cycle (28). Therefore, cell extracts were tested
for the acetyl-CoA- or propionyl-CoA- plus Mg-ATP-depen-
dent fixation of 14CO2 into acid-stable products, but no activity
was detected at 80°C. In addition, no malonyl-CoA reductase
or propionyl-CoA synthase activity could be detected (1
nmol min1 mg protein1). These enzymes are characteristic
of the 3-hydroxypropionate cycle in Chloroflexus aurantiacus,
and their activities could also be measured in Sulfolobales (1, 2,
28, 29, 31a). The presence of biotin proteins, such as the biotin
carrier protein of acetyl-CoA carboxylase or pyruvate carbox-
ylase, was investigated using the avidin technique. Extracts of I.
hospitalis showed no detectable biotin-containing protein,
whereas the small 18.6-kDa biotin carrier protein of acetyl-
CoA/propionyl-CoA carboxylase in M. sedula extract, which
served as a positive control, stained extremely strongly (not
shown). Also, no band with a molecular mass around 65 kDa
was visible. This would be the approximate size of the biotin-
containing subunit of pyruvate carboxylase (e.g., in Methano-
caldococcus jannaschii or Mycobacterium smegmatis, (36, 37).
These results exclude the operation of a 3-hydroxypropionate
cycle.
Members of the Thermoproteales exhibit a reductive citric
acid cycle for autotrophic CO2 fixation. Cell extracts of I.
hospitalis did not catalyze the 2-oxoglutarate- and CoA-depen-
dent reduction of viologen dyes or the exchange of 14CO2 into
2-oxoglutarate in the presence or absence of CoA (1 nmol
min1 mg protein1 at 75°C or 85°C), which is characteristic of
2-oxoglutarate–acceptor oxidoreductase, a key enzyme of this
cycle. Since pyruvate-acceptor oxidoreductase activity was
clearly detectable by the same methods (see below), the failure
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to detect 2-oxoglutarate–acceptor oxidoreductase was not due
to experimental failure but was most likely due to the absence
of this enzyme of the reductive citric acid cycle. In addition,
ATP citrate lyase activity was not detectable (1 nmol min1
mg protein1 at 75°C), excluding the reductive citric acid cycle
as a potential carbon fixation pathway.
In summary, no evidence for the operation of one of the
known CO2 fixation pathways was obtained. However, two
possible CO2-fixing enzyme activities were easily detected:
pyruvate-acceptor oxidoreductase activity was observed both in
the spectrophotometric assay with MV as the electron acceptor
(115  15 nmol min1 mg protein1 at 75°C) and in the
radioactive assay following the exchange of 14CO2 into the
carboxyl group (145  15 nmol min1 mg protein1 at 85°C).
In contrast, no pyruvate dehydrogenase or 2-oxoglutarate de-
hydrogenase activity was observed with NAD or NADP as
the electron acceptor (1 nmol min1 mg protein1 at 75°C).
Furthermore, PEP carboxylase was present and highly active
(202  20 nmol min1 mg protein1 at 85°C).
Enzyme activities in extracts of autotrophically grown cells.
The presence of pyruvate-acceptor oxidoreductases suggests
that acetyl-CoA is reductively carboxylated to pyruvate. There-
fore, enzyme activities possibly involved in biosynthesis starting
from pyruvate were investigated at 75°C or 85°C in cell extracts
of I. hospitalis. The results of the measurement are presented
in Table 1. Figure 1 gives an overview of the reactions involved.
Extracts catalyzed the PEP-dependent fixation of 14CO2 into
acid-stable products in the presence of NADH with a specific
activity of 202  20 nmol min1 mg protein1. Phosphate,
GDP, or ADP did not stimulate the reaction rate, excluding
activities of PEP carboxytransphosphorylase (requiring phos-
phate) (PEP  Pi  HCO3
 3 oxaloacetate  PPi) or PEP
carboxykinase (requiring GDP or ADP) (PEP  ADP 
HCO3
 3 oxaloacetate  ATP). These results suggest the
presence of PEP carboxylase activity catalyzing the formation
of oxaloacetate from PEP and CO2 (PEP  HCO3
 3 oxa-
loacetate  Pi), which was coupled to the reduction of oxalo-
acetate by NADH-dependent malate dehydrogenase.
PEP formation from pyruvate was tested by coupling PEP
conversion to malate catalyzed by endogenous PEP carboxyl-
ase and NADH-dependent malate dehydrogenase. Extracts
fixed 14CO2 in an Mg-ATP- and pyruvate-dependent reaction
in the presence of NADH with a specific activity of 210  10
nmol min1 mg protein1. The addition of phosphate did not
stimulate excluding the activity of pyruvate-phosphate dikinase
(pyruvate  ATP  Pi 3 PEP  AMP  PPi). The reaction
TABLE 1. Specific activities of enzymes of the central carbon metabolism in I. hospitalis
Enzyme EC no. No. of putativegenea
Incubation
temp (°C)
Sp act (nmol min1
mg protein1)
Citrate synthase 2.3.3.1 NF 75 21 4
2.3.3.3
ATP citrate lyase 2.3.3.8 NF 75 1
Aconitase 4.2.1.3 NF 75 31 2
Isocitrate dehydrogenase (NADP) 1.1.1.42 1027 75 240 20
2-Oxoglutarate dehydrogenase (NADP NAD) 1.2.1.52 NF 75 1
2-Oxoglutarate–acceptor oxidoreductase 1.2.7.3 NFb
MV 75 1
14CO2 exchange 85 1
Fumarate hydratase (class I) 4.2.1.2 658 75 895 45
Fumarate reductase (MV) 1.3.99.1 145 75 840 130
Malate dehydrogenase 1223
NAD 1.1.1.37 75 1,190 240
NAPD 1.1.1.82 75 745 100
Malyl-CoA lyase 4.1.3.24 NF 75 1
Pyruvate dehydrogenase (NAD NADP) 1.2.1.51 NF 75 1
Pyruvate-acceptor oxidoreductase 1.2.7.1 1217–1220
MV 75 115  15
14CO2 exchange 85 145  15
Pyruvate carboxylase 6.4.1.1 NF 85 1
Pyruvate kinase 2.7.1.40 NF 85 1
Pyruvate-phosphate dikinase 2.7.9.1 NF 85 1
Pyruvate-water dikinase 2.7.9.2 1075 85 210 10
PEP carboxylase 4.1.1.31 Present, gene not
annotated
85 202  20
PEP carboxykinase 4.1.1.32 NF 85 1
PEP carboxytransphosphorylase 4.1.1.38 NF 85 1
Lactate dehydrogenase (L-LDH, NAD) 1.1.1.27 NF 75 1
Lactate dehydrogenase (D-LDH, NAD) 1.1.1.28
Fructose 1,6-bisphosphatase 3.1.3.11 Present, gene not
annotated
85 146  4
Fructose 1,6-bisphosphate aldolase 4.1.2.13 NF 85 116 16
Glyceraldehyde 3-phosphate dehydrogenase 1.2.1.12 967 75
NADH 106  10
NADPH 270  10
a Derived from http://genome.jgi-psf.org/draft_microbes/ign_k/ign_k.draft.html. NF, not found.
b Two copies of genes coding for 2-oxoacid–acceptor oxidoreductases are present in the genome, one of which must definitely code for pyruvate-acceptor
oxidoreductase. The function of the other is unknown.
VOL. 189, 2007 AUTOTROPHIC PATHWAY IN IGNICOCCUS 4111
 o
n
 July 3, 2017 by INSTITUT FUER M
EERESKUNDE
http://jb.asm.org/
D
ow
nloaded from
 
was also not inhibited by avidin, which excludes oxaloacetate
formation via biotin-dependent pyruvate carboxylase (pyruvate
HCO3
  ATP 3 oxaloacetate  ADP  Pi). These results
indicate the presence of pyruvate-water dikinase (PEP syn-
thetase) (pyruvate  ATP  H2O 3 PEP  AMP  Pi).
Pyruvate kinase activity (PEP  ADP 3 pyruvate  ATP)
could not be detected.
The level of NAD(P)-dependent malate dehydrogenase
activity was high when oxaloacetate reduction with NADPH
(745  100 nmol min1 mg protein1) and NADH (1,190 
240 nmol min1 mg protein1) were tested. Fumarase activity,
measured in the direction of fumarate hydration, was 895 45
nmol min1 mg protein1. Fumarate reductase activity tested
with reduced MV as the electron donor was 840  45 nmol
min1 mg protein1.
Extracts catalyzed the formation of citrate from oxaloacetate
and acetyl-CoA with a specific activity of 21  4 nmol min1
mg protein1. This activity was oxygen sensitive and detectable
only under anoxic conditions. Since ATP citrate lyase activity
was not detectable (the observed reaction did not require ADP
and phosphate), this indicates the presence of a citrate syn-
thase. Aconitase activity turned out also to be oxygen sensitive
(30  2 nmol min1 mg protein1). Isocitrate dehydrogenase
was NADP specific (238  22 nmol min1 mg1). As indi-
cated above, both NAD(P) dependent 2-oxoglutarate dehy-
drogenase and 2-oxoglutarate–acceptor oxidoreductase activi-
ties were lacking. L-Malyl-CoA lyase activity was not detected.
Characteristic enzymes of gluconeogenesis were found.
3-Phosphoglycerate kinase and glyceraldehyde 3-phosphate
dehydrogenase activities were measured in one assay and were
clearly present (270  10 nmol min1 mg protein1), with a
preference of the dehydrogenase for NADPH. Similarly, fruc-
tose 1,6-bisphosphate aldolase and fructose 1,6-bisphosphate
phosphatase were measured in one assay, and both enzymes
were clearly detected (116  16 nmol min1 mg protein1 and
146  4 nmol min1 mg protein1, respectively, at 85°C).
Database search. The available genome database of I.
hospitalis (http://genome.jgi-psf.org/draft_microbes/ign_k/ign_k
.draft.html) was screened for the presence of putative genes
coding for autotrophic pathways (Table 1). The results are
summarized and visualized in Fig. 1.
Citric acid cycle. All putative genes for the citric acid cycle
were detected, except for an (si)-specific citrate synthase and a
2-oxoglutarate dehydrogenase (Table 1). Probes for (si)-spe-
cific citrate synthase used for screening the database were from
Thermus aquaticus, Pyrococcus furiosus, and Escherichia coli,
but all E values were e5. However, since citrate synthase
activity could be clearly detected, the gene encoding a putative
(re)-specific citrate synthase must be present. Its gene is not
known, and any annotation is therefore speculative. The genes
for isocitrate lyase, L-malate synthase, L-malyl-CoA lyase, ATP
citrate lyase, citrate lyase, and malic enzyme were not detected.
The genes for succinate dehydrogenase were most similar to
those of Sulfolobus acidocaldarius. However, it is unclear
whether fumarate reduction is catalyzed by the annotated suc-
cinate dehydrogenase or by a separate fumarate reductase. It
should be mentioned that two gene clusters containing the four
subunits of putative 2-oxoacid–acceptor oxidoreductases were
present. However, 2-oxoglutarate dehydrogenase or 2-oxoglu-
tarate–acceptor oxidoreductase activity was not detectable, in
contrast to pyruvate-acceptor oxidoreductase activity. These
data taken together suggest the presence of an incomplete
citric acid cycle that serves solely anabolic purposes. However,
the nature of citrate synthase remains elusive.
Pyruvate and PEP synthesis and C-3 and C-4 interconver-
sion. The putative genes for pyruvate-acceptor oxidoreductase
(pyruvate synthase) were found; in contrast, pyruvate dehydro-
genase genes were not found. Furthermore, a putative gene for
pyruvate-water dikinase (PEP synthetase) that forms PEP was
detected. The corresponding genes for pyruvate-phosphate
dikinase or pyruvate kinase were not seen. The putative gene
for PEP carboxylase was present. The alternative routes of
oxaloacetate synthesis from pyruvate via pyruvate carboxylase,
as well as PEP carboxykinase and PEP carboxytransphos-
phorylase, seem not to be present, since these genes were not
detected. This suggests that acetyl-CoA is reductively carbox-
ylated to pyruvate by pyruvate synthase and then converted to
FIG. 1. Biosynthetic capacity of I. hospitalis, according to genome
data. Circles, putative genes of enzymes that were detected (E value 
e11); squares, genes of enzymes that were not detected in the I.
hospitalis genome. The numbers of the putative genes of the I. hospi-
talis genome are shown: 1a, citrate synthase; 1b, ATP citrate lyase; 2,
aconitase; 3, isocitrate dehydrogenase; 4a, malate dehydrogenase; 4b,
malate quinone oxidoreductase; 5, fumarate hydratase; 6a, fumarate
reductase; 6b, succinate dehydrogenase; 7, succinate-CoA ligase (ADP
forming); 8a, 2-oxoacid–ferredoxin oxidoreductase; 8b, acetyl-CoA
carboxylase; 8c, pyruvate dehydrogenase; 9a, pyruvate-water dikinase;
9b, pyruvate-phosphate dikinase; 9c, pyruvate kinase; 10a, PEP car-
boxylase; 10b, PEP carboxykinase; 10c, PEP carboxytransphosphory-
lase; 11, pyruvate carboxylase; 12, enolase; 13, phosphoglycerate mu-
tase; 14, phosphoglycerate kinase; 15, glyceraldehyde 3-phosphate
dehydrogenase; 16, triosephosphate isomerase; 17, fructose 1,6-
bisphosphate aldolase; 18, fructose 1,6-bisphosphate phosphatase; 19,
phosphoglucose isomerase (cupin type); 20, 3-hexulose 6-phosphate
isomerase; 21, 3-hexulose 6-phosphate synthase.
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PEP by PEP synthetase and that PEP then gives rise to
oxaloacetate via PEP carboxylase.
Gluconeogenesis from PEP and pentosephosphate synthe-
sis. Gluconeogenesis from PEP via fructose 1,6-bisphosphate
and fructose 6-phosphate seems to proceed in the conventional
way, with some remarkable exceptions regarding the nature of
the enzymes. The putative genes coding for enolase, phospho-
glycerate mutase, phosphoglycerate kinase, glyceraldehyde
3-phosphate dehydrogenase, and triosephosphate isomerase
were found. A gene coding for fructose 1,6-bisphosphate
aldolase was not detected. The same was true for the classical
hexosephosphate isomerase. However, a 1-phosphoglucose
isomerase of the cupin superfamily was found, although with
only a low E value (e11) for the corresponding gene from
Thermococcus litoralis; this gene product is thought to act as
hexosephosphate isomerase. A putative fructose 1,6-bisphos-
phate phosphatase gene was found. In contrast, the genes for
the classical enzymes of the pentose phosphate pathway, glu-
cose 6-phosphate dehydrogenase, 6-phosphogluconolactone
hydrolase, and 6-phosphogluconate dehydrogenase, were lack-
ing. Instead, the two genes for the enzymes of the recently
proposed ribulose monophosphate pathway of pentosephos-
phate synthesis, 3-hexulose 6-phosphate isomerase and 3-hex-
ulose 6-phosphate synthase, were present.
Glycolysis. Genes for enzymes of the nonphosphorylating or
phosphorylating Entner-Doudoroff pathway could not be
found. Also, the genes coding for glucokinase and phospho-
fructokinase of a (modified) Embden-Meyerhof pathway were
not detected. The gene for pyruvate-kinase was also not de-
tected. However, it should be mentioned that in Archaea, PEP
synthase can function as pyruvate kinase, as well (31). The
genes coding for glyceraldehyde 3-phosphate–ferredoxin
oxidoreductase (EC 1.2.7.6) and nonphosphorylative
NAD- or NADP-dependent glyceraldehyde 3-phosphate
dehydrogenase (EC 1.2.1.9 or EC 1.2.1.12, respectively)
were missing. However, the gene for NAD(P)-dependent
phosphorylative D-glyceraldehyde 3-phosphate dehydroge-
nase (EC 1.2.1.59) was present (see above) and likely func-
tions in gluconeogenesis.
Incorporation of 14C-labeled acetate, pyruvate, succinate,
and glucose. I. hospitalis was grown autotrophically under an-
aerobic conditions with hydrogen as the electron donor and
elemental sulfur as the electron acceptor (25). To test the
incorporation of organic substrates, 14C-labeled acetate, pyru-
vate, succinate, or glucose was added to the medium at a
concentration of 0.5 mM (Table 2). The generation time of I.
hospitalis was about 60 min in all experiments, and cells were
harvested at the end of the exponential growth phase. Figure 2
shows the accumulation of radioactivity from each labeled
compound in the cell pellet and the decrease of radioactivity in
the cell-free medium during growth. The organic compounds
contributed to different extents to the cell material. Approxi-
mately 5.2% of the proffered labeled acetate, 3.5% of the
pyruvate, 1.9% of the succinate, and 0% of the glucose were
incorporated. In the experiments with pyruvate and succinate,
losses of total radioactivity of 31% and 44%, respectively, oc-
curred, which were most probably caused by the release of
14CO2 produced from the labeled compounds.
Calculating the mass of carbon derived from the proffered
organic compound and comparing it with the cell mass, acetate
TABLE 2. Incorporation rates of organic substrates into I. hospitalis cell carbona
Labeled proffered compound
(0.5 mM/250 ml growth
medium)
Specific radioactivity
of labeled proffered
compound
(dpm nmol1)
Cells formed
(g protein ml1)
14C in cell pellet
(dpm ml1)
C in cell pellet from
labeled proffered
compound (g ml1)
% Cell carbon derived
from labeled
compound
[1-14C]acetate (140 kBq) 68 5.4 1,782 0.629 11.6
[3-14C]pyruvate (630 kBq) 300 7.2 5,127 0.615 8.5
[1,4-14C]succinate (140 kBq) 68 5.4 670 0.473 8.8
a Calculated from the incorporation of 14C-labeled compounds. Cells were harvested at a cell concentration of about 6  106 ml1.
FIG. 2. Incorporation of 14C-labeled substrates by growing I.
hospitalis cells. (A) [1-14C]acetate. (B) [1,4-14C]succinate. (C) [3-
14C]pyruvate. (D) [U-14C]glucose. The total radioactivities in the
assay (f), in the supernatant/cell-free medium (}), and in the cells
(Œ) in relation to the dry cell mass () of the growing I. hospitalis
culture are shown.
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TABLE 3. 13C abundances of amino acids from I. hospitalis autotrophically grown in the presence of 0.5 mM [1-13C]acetate
Amino acid Position Chemical shift
	 (ppm) Relative
13C (%) Corresponding position(s)a
Alanine 1 171.0 NDb 1 (pyruvate), CO2
2 50.7 16.8 2 (pyruvate), 1 (acetyl-CoA)
3 17.8 3.3 3 (pyruvate), 2 (acetyl-CoA)
Serine 1 173.6 ND 1 (PEP)
2 53.3 15.3 2 (PEP)
3 57.9 3.3 3 (PEP)
Aspartate 1 180.7 1.1 1 (oxaloacetate), 1 (pyruvate), CO2
2 54.4 14.5 2 (oxaloacetate), 2 (pyruvate), 1 (acetyl-CoA)
3 43.7 4.6 3 (oxaloacetate), 3 (pyruvate), 2 (acetyl-CoA)
4 182.8 1.1 4 (oxaloacetate), CO2
Threonine 1 ND ND 1 (oxaloacetate), 1 (pyruvate), CO2
2 56.9 14.0 2 (oxaloacetate), 2 (pyruvate), 1 (acetyl-CoA)
3 63.9 3.3 3 (oxaloacetate), 3 (pyruvate), 2 (acetyl-CoA)
4 14.2 1.1 4 (oxaloacetate), CO2
Isoleucine 1 171.6 18.1 1 (acetyl-CoA)
2 57.6 2.2 2 (acetyl-CoA)
3 39.1 14.9 2 (pyruvate), 1 (acetyl-CoA)
4 24.9 6.2 2 (pyruvate), 1 (acetyl-CoA)
5 11.4 1.1 3 (pyruvate), 2 (acetyl-CoA)
6 14.5 1.3 3 (pyruvate), 2 (acetyl-CoA)
Glutamate 1 183.3 20.0 1 (oxoglutarate), 1 (acetyl-CoA)
2 56.3 5.3 2 (oxoglutarate), 2 (acetyl-CoA)
3 32.2 16.9 3 (oxoglutarate), 2 (oxaloacetate), 2 (pyruvate), 1 (acetyl-CoA)
4 34.5 5.7 4 (oxoglutarate), 3 (oxaloacetate), 3 (pyruvate), 2 (acetyl-CoA)
5 183.5 1.1 5 (oxoglutarate), 4 (oxaloacetate), CO2
Proline 1 171.6 19.7 1 (oxoglutarate), 1 (acetyl-CoA)
2 59.5 4.0 2 (oxoglutarate), 2 (acetyl-CoA)
3 28.3 12.9 3 (oxoglutarate), 2 (oxaloacetate), 2 (pyruvate), 1 (acetyl-CoA)
4 23.5 4.1 4 (oxoglutarate), 3 (oxaloacetate), 3 (pyruvate), 2 (acetyl-CoA)
5 46.5 1.1 5 (oxoglutarate), 4 (oxaloacetate), CO2
Arginine 1 170.0 11.0 1 (oxoglutarate), 1 (acetyl-CoA)
2 50.8 6.7 2 (oxoglutarate), 2 (acetyl-CoA)
3 25.3 14.5 3 (oxoglutarate), 2 (oxaloacetate), 2 (pyruvate), 1 (acetyl-CoA)
4 22.2 5.2 4 (oxoglutarate), 3 (oxaloacetate), 3 (pyruvate), 2 (acetyl-CoA)
5 38.8 1.1 5 (oxoglutarate), 4 (oxaloacetate), CO2
6 164.1 3.1
Lysine 1 171.9 22.6 1 (acetyl-CoA)
2 51.5 7.6 2 (acetyl-CoA)
3 27.0 6.9 2 (oxoglutarate), 2 (acetyl-CoA)
4 18.7 26.3 3 (oxoglutarate), 2 (oxaloacetate), 2 (pyruvate), 1 (acetyl-CoA)
5 23.5 7.7 4 (oxoglutarate), 3 (oxaloaceate), 3 (pyruvate), 2 (acetyl-CoA)
6 36.2 1.1 5 (oxoglutarate), 4 (oxaloacetate), CO2
Histidine 1 165.5 3.1 5 (ribose 5-phosphate)
2 51.6 13.5 4 (ribose 5-phosphate)
3 21.3 1.1 3 (ribose 5-phosphate)
4 134.1 2.4 2 (ribose 5-phosphate)
5 118.2 15.0 1 (ribose 5-phosphate)
6 146.1 1.3
Phenyl-alanine 1 182.4 ND 1 (PEP)
2 57.4 44 2 (PEP)
3 40.7 4 3 (PEP)
4 138.2 26.9 2 (PEP)
5/9 129.4 2.6 3 (PEP)/4 (erythrose 4-phosphate)
6/8 128.5 5.4 3/1 (erythrose 4-phosphate)
7 126.6 1.1 2 (erythrose 4-phosphate)
Tyrosine 1 183.4 1.1 1 (PEP)
2 57.9 43 2 (PEP)
3 40.3 5 3 (PEP)
4 123.6 22.7 2 (PEP)
5/9 131.1 7.6 3 (PEP)/4 (erythrose 4-phosphate)
6/8 119.1 9.9 3/1 (erythrose 4-phosphate)
7 165.0 ND 2 (erythrose 4-phosphate)
a On the basis of the metabolic network in I. hospitalis, equivalent positions in the respective building blocks of the index amino acid are indicated.
b ND, not determined.
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contributed 11.6%, pyruvate 8.5%, and succinate 8.8% to the
cell carbon (Table 2). Thus, the contribution of the proffered
organic carbon to the cell carbon at the time of harvest of the
cultures was 12% in all cases; the rest of the cell carbon
should have been derived from CO2. These values were calcu-
lated from the specific radioactivity of the total carbon of the
proffered organic compounds, the amount of 14C incorporated
into the cell pellet, and the amount of protein formed, assum-
ing 1 g of dry cell mass was equal to 0.5 g of cell protein or 0.5 g
of cell carbon, respectively.
This obligate autotrophic archaeon, like other obligate au-
totrophic microorganisms, obviously is able to assimilate to a
certain extent external carbon sources, such as acetate. Assim-
ilation of acetate requires an acetate-activating enzyme, and
the gene coding for an acetate-CoA ligase (AMP forming) was
detected in the genome, whereas genes for acetate kinase and
phosphotransacetylase were not found. Succinate and pyruvate
assimilation do not need activation, and uptake may proceed
by passive diffusion of the protonated form of the carboxylic
acids. Glucose apparently was not taken up.
Labeling of growing cells with 13C-labeled compounds and
distribution of 13C in individual building blocks. Cells were
grown for at least six generations in the presence of 0.5 mM
[1-13C]acetate, and then amino acids were isolated from the
protein fraction and the 13C distributions in the individual
carbon positions of the amino acids were determined by 13C
NMR spectroscopy (Table 3). The values indicate that in this
experiment up to 20% of the basic building blocks of amino
acids were derived from carbons of the exogenous acetate
precursor.
The retrobiosynthetic approach allows a determination of
the labeling pattern of intermediates of the central carbon
metabolism from the amino acid patterns (3). For instance, the
labeling pattern of alanine directly reflects the labeling pattern
of its precursor molecule, pyruvate. Conversely, the labeling of
the building blocks allows predictions as to the biosynthetic
pathway, once the labeling pattern of central intermediates
and the topology of the metabolic network have been deduced
(Fig. 3 and Table 3). The averaged reconstructed 13C distri-
butions in the central intermediates, acetyl-CoA, pyruvate,
oxaloacetate, 2-oxoglutarate, and ribose-5-phosphate, are
given in Table 4.
Acetyl-CoA is the starting point of the postulated new au-
totrophic CO2 fixation pathway. The dominant labeling of
acetyl-CoA at C-1 reflects the labeling of the precursor mole-
cule. C-2 was also weakly labeled, indicating either that the
FIG. 3. Proposed incomplete pathway of CO2 fixation in I. hospi-
talis. The proposed pathway was deduced from the labeling pattern
and the complement of enzymes and genes of I. hospitalis. The circles
represent highly 13C-enriched carbon atoms from [1-13C]acetate. Par-
tial randomization of labeling in oxaloacetate is explained by reversible
reactions between oxaloacetate, malate, fumarate, and succinate. A
reductive carboxylation of succinyl-CoA implies a lack of 13C enrich-
ment at C-1 of 2-oxoglutarate. This is at odds with the labeling data for
glutamate, proline, and arginine, which all display high 13C enrichment
at C-1. The compounds in boxes were analyzed.
TABLE 4. Rule-derived 13C abundances in central metabolites of
I. hospitalis autotrophically grown in the presence of
0.5 mM [1-13C]acetatea
Metabolite Position % 13C Reconstructed andaveraged from:
Acetyl-CoA 1 16.3 4.9 Ala, Asp, Thr, Ile, Glu,
Pro, Arg, Lys
2 4.6  2.1 Ala, Asp, Thr, Ile, Glu,
Pro, Arg, Lys
Pyruvate 1 1.1 Asp
2 15.2  5.2 Ala, Asp, Thr, Ile, Glu,
Pro, Arg, Lys
3 4.0  2.1 Ala, Asp, Thr, Ile, Glu,
Pro, Arg, Lys
Oxaloacetate 1 1.1 Asp
2 16.5  4.9 Asp, Thr, Ile, Glu, Pro,
Arg, Lys
3 5.1  1.5 Asp, Thr, Ile, Glu, Pro,
Arg, Lys
4 1.1  0 Asp, Thr, Ile, Glu, Pro,
Arg, Lys
2-Oxoglutarate 1 16.9 5.1 Glu, Pro, Arg
2 5.7  1.3 Glu, Pro, Arg, Lys
3 17.6  5.9 Glu, Pro, Arg, Lys
4 5.7  1.5 Glu, Pro, Arg, Lys
5 1.1  0 Glu, Pro, Arg, Lys
Ribose 5-phosphate 1 15.0 His
2 2.4 His
3 1.1 His
4 13.5 His
5 3.1 His
a The data are reconstructed and averaged from isotopologue profiles in
amino acids (cf. Table 3).
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formation of acetyl-CoA from other intermediates was only
marginal or that acetyl-CoA, the presumed CO2 acceptor mol-
ecule and starting point of the postulated CO2 fixation path-
way, is re-formed in a cyclic process resulting again in a prom-
inent label accumulation in C-1 rather than in C-2.
All of the data can be integrated into a hypothetical pathway
of CO2 fixation in I. hospitalis (Fig. 3) that is still incomplete.
The labeling of pyruvate predominantly at C-2 is consistent
with its synthesis from acetyl-CoA and CO2 via pyruvate syn-
thase. Oxaloacetate was strongly labeled at C-2, which is also
consistent with its biosynthesis from pyruvate via PEP. The
partial acquisition of label in C-3 is probably due to the ran-
domization that occurs when oxaloacetate partly equilibrates
with symmetric fumarate or succinate.
Interestingly, the labeling of 2-oxoglutarate preferentially at
C-1 and C-3 is consistent with its synthesis via citrate and
isocitrate involving a (re)-specific citrate synthase. The opera-
tion of a (si)-specific enzyme would result in the formation of
C-3- and C-5-labeled 2-oxoglutarate. In any case, the reductive
carboxylation of succinyl-CoA can be excluded, since a random
labeling of C-3 and C-4 would be expected, and in no case
should C-1 be labeled.
The labeling of ribose 5-phosphate preferentially at C-1 and
C-4 (deduced from the labeling of histidine) indicates that
hexose phosphate labeled at C-2 and C-5 was presumably an
intermediate (the biosynthetic pathway is shown in Fig. 4). This
pattern is consistent with the synthesis of fructose 1,6-bisphos-
phate from two molecules of C-2-labeled pyruvate via gluconeo-
genesis and conversion of hexosephosphate to pentosephos-
phate via the ribulose-monophosphate pathway (see “Special
biosynthetic pathways” below).
Special biosynthetic pathways. Pentosephosphate may be
formed by oxidation and loss of C-1 as CO2 in the classical
oxidative pentose phosphate pathway or via release of form-
aldehyde from C-1 in the novel archaeal ribulose monophos-
phate pathway (13, 33, 45) (Fig. 4). Due to the cleavage of
C-1, both pathways lead to identical labeling patterns of the
resulting pentosephosphates. However, the genome data suggest
the operation of the ribulose-monophosphate pathway in I.
hospitalis.
Biosynthesis of aromatic compounds may proceed either via
the classical pathway that starts from erythrose 4-phosphate
and PEP or via the novel pathway that starts from L-aspartate
semialdehyde and 6-deoxy-5-keto-fructose-1-phosphate (49).
Coincidentally, the labeling patterns that can be predicted to
arise from [1-13C]acetate via the two alternatives are very sim-
ilar (Fig. 5). The apparent enrichment detected for the ortho
ring positions in phenylalanine and tyrosine, albeit weak, might
suggest the involvement of the aspartate semialdehyde path-
way. In the genome, however, both genes for the initial two
enzymes of the classical pathway, 3-deoxy-D-arabino-heptu-
losonate 7-phosphate synthase and 3-dehydroquinate synthase,
were present, whereas genes with similarity to the two genes
for the new pathway were not found. In addition, a transke-
tolase gene, characteristic of the “classical” pathway of biosyn-
thesis of aromatic amino acids, was found in the genome of
I. hospitalis. All known organisms using the aspartate semi-
aldehyde pathway lack the gene for this enzyme in their
genomes (45).
Biosynthesis of lysine may proceed via the common di-
aminopimelate pathway from pyruvate and aspartate or via
the 
-aminoadipate pathway, whereby 2-oxoglutarate and
acetyl-CoA are condensed and then converted to 2-oxoadipate
in much the same way as 2-oxoglutarate is formed in the citric
acid cycle (4, 41). The 13C labeling pattern clearly conforms to
the second option (Fig. 6).
Biosynthesis of isoleucine via 
-ketobutyrate may proceed
either via aspartate and threonine or starting from acetyl-CoA
and pyruvate (Fig. 7). The detected labeling pattern in isoleu-
cine clearly excludes a biosynthetic pathway via threonine as
an intermediate but is perfectly in line with the so-called
citramalate pathway via pyruvate (6, 8, 41).
FIG. 4. Biosynthesis of histidine via fructose 6-phosphate from
two molecules of PEP. (Left column) Formation of ribulose 5-phos-
phate by oxidative decarboxylation. (Right column) Formation of
ribulose 5-phosphate by the ribulose monophosphate pathway. PHI,
3-hexulose 6-phosphate isomerase; HPS, 3-hexulose 6-phosphate
synthase. The circles represent 13C-enriched carbon atoms from
[1-13C]acetate. The observed labeling pattern in histidine is shown
in the box. The lowercase characters in histidine and ribose phos-
phate indicate biosynthetically equivalent carbon atoms.
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DISCUSSION
Evidence for a new autotrophic pathway in I. hospitalis. The
present work provides substantial arguments in favor of a new
autotrophic CO2 fixation pathway in I. hospitalis. RubisCo ac-
tivity was not detected, nor was the corresponding gene coding
for either enzyme form I, II, or III found in the genome. The
gene for a RubisCo-like protein was also not seen. Therefore,
the Calvin cycle obviously does not work in I. hospitalis. The
reductive acetyl-CoA pathway is excluded for the same rea-
sons. CO dehydrogenase activity and the genes coding for this
enzyme were not found. The citric acid cycle was found to be
incomplete, lacking a 2-oxoglutarate-oxidizing enzyme activity.
Also, no ATP citrate lyase activity was detected, nor was the
corresponding gene found in the genome. In addition, the
labeling pattern of glutamate proved that C-1 was derived from
C-1 of acetyl-CoA rather than from CO2. The (modified) 3-hy-
droxypropionate cycle cannot be operative, since acetyl-CoA
carboxylase activity was lacking and the corresponding genes
were not found, nor could significant amounts of biotin-depen-
dent enzymes be detected in cell extracts. All three criteria
FIG. 6. Biosynthesis of lysine. (Left column) Formation of lysine via
the common pathway starting from aspartate and pyruvate and leading to
diaminopimelate. (Right column) Formation of lysine via the uncommon
pathway starting from 2-oxoglutarate and acetyl-CoA and leading to

-aminoadipate. The circles represent 13C-enriched carbon atoms from
[1-13C]acetate. The observed labeling pattern in lysine is shown in the box.
The labeling pattern of 2-oxoglutarate is reconstructed from the observed
pattern in glutamate, proline, and arginine.
FIG. 7. Biosynthesis of isoleucine. (Left column) Formation of iso-
leucine via the conventional pathway in which 2-oxobutyrate is formed
from threonine. The labeling pattern of threonine corresponds to that
of aspartate from which it is formed (Table 3). (Right column) For-
mation of isoleucine via the unconventional pathway in which 2-oxobu-
tyrate is formed from pyruvate and acetyl-CoA via citramalate and
3-methyloxaloacetate, which is decarboxylated to 2-oxobutyrate. Note
that the labeling of 2-oxobutyrate differs in the two pathways. The
subsequent steps from 2-oxobutyrate to isoleucine are identical.
The circles represent 13C-enriched carbon atoms from [1-13C]ac-
etate. The observed labeling patterns in threonine and isoleucine
are shown in boxes. The labeling pattern of pyruvate is recon-
structed from the observed pattern in alanine.
FIG. 5. Biosynthesis of phenylalanine via fructose 6-phosphate.
(Left column) Synthesis of erythrose 4-phosphate by reaction of the
nonoxidative pentose phosphate pathway. TK, transketolase; TA,
transaldolase. The labeling pattern of dehydroshikimate is constructed
from erythrose 4-phosphate and PEP on the basis of the conventional
shikimate pathway. (Right column) Synthesis via 6-deoxy-5-ketofruc-
tose 1-phosphate and aspartate semialdehyde. The labeling pattern of
aspartate semialdehyde was predicted from that of aspartate.
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were met by M. sedula, a member of the Sulfolobales, which are
postulated to use a modified 3-hydroxypropionate cycle.
Postulated CO2-fixing enzymes. Extracts contained pyru-
vate-acceptor oxidoreductase and PEP carboxlase activities.
The specific activities at 85°C were approximately 200 nmol
min1 mg protein1. The required specific CO2 fixation rate at
a generation time of 2 h is around 400 nmol CO2 fixed min
1
mg protein1. If the new pathway comprises two CO2 fixation
steps, as indicated, the minimal specific enzyme activity of each
of the two carboxylating enzymes should be on the order of 200
nmol min1 mg protein1. It should be noted that the enzyme
assays have not been optimized and the activity was tested in
the direction of pyruvate oxidation with MV as the electron
acceptor or by following the incorporation of label from 14CO2
into the carboxyl group via the isotope exchange reaction. In
growing cells, the reduction of ferredoxin may be brought
about by energy-driven reverse electron transport from NAD(P)H,
allowing an effective reductive carboxylation of acetyl-CoA
(20). The acetate-labeling experiment clearly showed that pyru-
vate synthase indeed functions in the reductive-carboxylation di-
rection. A similar phenomenon has been observed in Meth-
anobacterium thermoautotrophicum strain Marburg (renamed
Methanothermobacter marburgensis), where acetyl-CoA is con-
verted unidirectionally into pyruvate (11, 46). PEP carboxylation
to oxaloacetate by PEP carboxylase is also supported by the la-
beling pattern of aspartate, where C-4 is derived from CO2.
Proposed outline of biosynthetic pathways starting from
acetyl-CoA. We propose that the autotrophic CO2 fixation
pathway starts from acetyl-CoA. Therefore, we analyzed the
assimilation of acetate into cellular building blocks under con-
ditions where 80% of the cell carbon is still derived from CO2.
The observed labeling pattern, together with positive or neg-
ative enzyme activity assays and supported by a database
search of the genome, are consistent with the following scheme
(if not otherwise mentioned, the putative corresponding genes
were detected in the genome) (Fig. 1). Acetyl-CoA is reduc-
tively carboxylated to pyruvate by pyruvate synthase (see
above). Pyruvate is converted into PEP by pyruvate-water diki-
nase (PEP synthase), and carboxylation of PEP by PEP car-
boxylase produces oxaloacetate. The citric acid cycle is in-
complete and serves only anabolic functions. 2-Oxoglutarate
oxidation is missing. Interestingly, the labeling experiments
clearly showed that citrate synthase is citrate (re)-synthase (EC
2.3.3.3.) rather than the common (si)-synthase (EC 2.3.3.1.).
These two enzymes differ with respect to the side to which acetyl-
CoA is added to C-2 of oxaloacetate. They can be discriminated
if carbon isotope-labeled acetyl-CoA is used, resulting in chiral
citrate (use of unlabeled acetate results in prochiral citrate).
Chiral citrate is then converted asymmetrically to 2-oxoglutarate,
resulting in differently labeled glutamate. In line with this finding,
no citrate (si)-synthase gene was found in the genome.
Gluconeogenesis from PEP appears to be conventional, in-
cluding a NAD(P)-dependent glyceraldehyde 3-phosphate
dehydrogenase. A fructose 1,6-bisphosphate aldolase gene
was not detected; however, cell extracts exhibited fructose
1,6-bisphosphate aldolase activity. Fructose 1,6-bisphos-
phate phosphatase was active in cell extracts, and a putative
gene was detected in the genome (see below).
Pentosephosphates are likely derived from hexosephosphate
by loss of C-1. The database suggests that this is brought about
by enzymes of the ribulose monophosphate pathway (formalde-
hyde released from C-1) rather than by enzymes of the oxidative
pentose phosphate pathway (CO2 released from C-1).
Catabolic potential. Cultures of I. hospitalis cannot grow on
sugars (38), and this inability is reflected by the gene outfit and
the enzyme pattern. Genes for key enzymes of glycolytic path-
ways (44) in Archaea are apparently not present. These include
genes for enzymes of the phosphorylating and nonphosphory-
lating Entner-Doudoroff pathway and genes encoding glucoki-
nase and phosphofructokinase of a (modified) Embden-
Meyerhof pathway, as well as pyruvate kinase and pyruvate
dehydrogenase. In accordance with this, neither pyruvate kinase
nor pyruvate dehydrogenase activity was detected in cell extracts
of I. hospitalis. Also, we showed that growing I. hospitalis cells are
obviously unable to incorporate glucose. Taken together, the data
suggest that I. hospitalis is unable to gain energy or low-molecular-
weight building blocks from oxidizing sugars.
Special enzymes and biosynthetic pathways. The central car-
bon metabolism of I. hospitalis has some special features that
are only partly common to Archaea. Citrate synthase is (re)-
specific. The corresponding gene has not been detected yet; a
gene with similarity to (si)-specific citrate synthase is missing,
indicating that the re-specific enzyme is completely differ-
ent. Citrate (re)-synthase has been reported in Desulfovibrio
vulgaris, Desulfovibrio desulfuricans, Clostridium kluyveri, Clos-
tridium acidiurici, and Clostridium cylindrosporum (14–17). The
gene for citrate (re)-synthase has been identified as a member
of the isopropylmalate synthase enzyme family by expressing
the Ignicoccus gene in E. coli and studying the reaction catalyzed
by the enzyme (G. Fuchs and R. Say, unpublished results).
PEP carboxylase is a member of the archaeal-type carboxylase
(39). Fructose 1,6-bisphosphate aldolase appears to be different
from the known enzyme, since activity was detected but a data-
base search did not yield any hit. Glucose 6-phosphate isomerase
seems to be a member of the CUPIN superfamily (18, 19, 47), an
archaeal enzyme type that was found in several members of the
Euryarchaeotes. The new pathway of pentose phosphate synthesis
(13, 33, 45), rather than the common oxidative pentose phosphate
pathway, seems to be operative, based on the gene outfit and the
labeling pattern, which is consistent with this pathway.
Lysine is synthesized via the unconventional 
-aminoadipate
pathway, rather than via the conventional diaminopimelate
pathway. The 
-aminoadipate pathway is common in eu-
karyotes but was also found in Thermoproteus neutrophilus
within the prokaryotes (42). The biosynthesis of the aromatic
amino acids seems to proceed via the shikimate pathway, start-
ing from erythrose 4-phosphate and PEP. Isoleucine is made
from 
-ketobutyrate, which seems to be assembled from pyru-
vate and acetyl-CoA but not from threonine. This citramalate
pathway (6) is also found in some other Archaea (3, 8, 23, 42).
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